Perrigo Co Plc - Company Profile
Powered by
All the data and insights you need on Perrigo Co Plc in one report.
- Save hours of research time and resources with
our up-to-date Perrigo Co Plc Strategy Report
- Understand Perrigo Co Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Perrigo Co Plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic, specialty pharmaceutical company, nutritional products, and infant formulas and foods. The company’s major products include analgesics, gastrointestinal, personal care and derma therapeutics, clobetasol spray, clindamycin foam, mupirocin ointment, Ketoconazole, halobetasol ointment and cream and permethrin cream. It markets products through wholesalers, retail drugs, supermarket and mass merchandise chains and direct sales representatives. The company has operational presence in various geographical regions such as Australia, Israel and China. Perrigo is headquartered in Dublin, Ireland.
Perrigo Co Plc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Analgesics | Advil |
Antacids/anti-gas Products | Afrin |
Anti-Diarrheal Products | Alavert |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Others | In August, Perrigo and Mead Johnson Nutrition secured the US FDA warning letters for baby formula. |
2023 | Regulatory Approval | In July, the company received the US FDA approval for Opill, a progestin-only daily oral contraceptive, for over-the-counter use for all ages. |
2023 | Regulatory Approval | In May, the company received final approval from the U.S. Food and Drug Administration for Nicotine Coated Mint Lozenges, 2 mg and 4 mg over-the-counter (OTC). |
Competitor Comparison
Key Parameters | Perrigo Co Plc | Johnson & Johnson | The Procter & Gamble Co | Pfizer Inc | Bayer AG |
---|---|---|---|---|---|
Headquarters | Ireland | United States of America | United States of America | United States of America | Germany |
City | Dublin | New Brunswick | Cincinnati | New York | Leverkusen |
State/Province | - | New Jersey | Ohio | New York | Nordrhein-Westfalen |
No. of Employees | 9,140 | 131,900 | 107,000 | 88,000 | 99,723 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Rolf A. Classon | Chairman | Executive Board | 2017 | - |
Patrick Lockwood-Taylor | President; Director; Chief Executive Officer | Executive Board | 2023 | - |
Thomas M. Farrington | Chief Information Officer; Executive Vice President | Senior Management | 2015 | - |
Grainne Quinn | Chief Medical Officer; Executive Vice President | Senior Management | 2016 | - |
Alison Ives | Executive Vice President; Chief Scientific Officer | Senior Management | 2022 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward